• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 中人类肠道微生物组感染能力的改变。

Altered infective competence of the human gut microbiome in COVID-19.

机构信息

Systems Ecology Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Clinical and Applied Virology, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.

出版信息

Microbiome. 2023 Mar 9;11(1):46. doi: 10.1186/s40168-023-01472-7.

DOI:10.1186/s40168-023-01472-7
PMID:36894986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995755/
Abstract

BACKGROUND

Infections with SARS-CoV-2 have a pronounced impact on the gastrointestinal tract and its resident microbiome. Clear differences between severe cases of infection and healthy individuals have been reported, including the loss of commensal taxa. We aimed to understand if microbiome alterations including functional shifts are unique to severe cases or a common effect of COVID-19. We used high-resolution systematic multi-omic analyses to profile the gut microbiome in asymptomatic-to-moderate COVID-19 individuals compared to a control group.

RESULTS

We found a striking increase in the overall abundance and expression of both virulence factors and antimicrobial resistance genes in COVID-19. Importantly, these genes are encoded and expressed by commensal taxa from families such as Acidaminococcaceae and Erysipelatoclostridiaceae, which we found to be enriched in COVID-19-positive individuals. We also found an enrichment in the expression of a betaherpesvirus and rotavirus C genes in COVID-19-positive individuals compared to healthy controls.

CONCLUSIONS

Our analyses identified an altered and increased infective competence of the gut microbiome in COVID-19 patients. Video Abstract.

摘要

背景

SARS-CoV-2 感染对胃肠道及其常驻微生物群有明显影响。据报道,严重感染病例与健康个体之间存在明显差异,包括共生分类群的丧失。我们旨在了解微生物组的改变,包括功能转变,是否仅存在于严重病例中,还是 COVID-19 的常见影响。我们使用高分辨率系统多组学分析,对无症状至中度 COVID-19 个体与对照组的肠道微生物组进行了分析。

结果

我们发现 COVID-19 中,毒力因子和抗生素耐药基因的总体丰度和表达都显著增加。重要的是,这些基因是由 Acidaminococcaceae 和 Erysipelatoclostridiaceae 等家族的共生分类群编码和表达的,我们发现这些分类群在 COVID-19 阳性个体中富集。与健康对照组相比,我们还发现 COVID-19 阳性个体中 beta 疱疹病毒和轮状病毒 C 基因的表达增加。

结论

我们的分析确定了 COVID-19 患者肠道微生物组改变和增加的感染能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/e6be4e89047c/40168_2023_1472_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/5266d7621d92/40168_2023_1472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/f968ebfc2498/40168_2023_1472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/653ad89463e6/40168_2023_1472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/5aa298eca472/40168_2023_1472_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/3847e6a0619a/40168_2023_1472_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/e6be4e89047c/40168_2023_1472_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/5266d7621d92/40168_2023_1472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/f968ebfc2498/40168_2023_1472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/653ad89463e6/40168_2023_1472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/5aa298eca472/40168_2023_1472_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/3847e6a0619a/40168_2023_1472_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b870/9996881/e6be4e89047c/40168_2023_1472_Fig6_HTML.jpg

相似文献

1
Altered infective competence of the human gut microbiome in COVID-19.COVID-19 中人类肠道微生物组感染能力的改变。
Microbiome. 2023 Mar 9;11(1):46. doi: 10.1186/s40168-023-01472-7.
2
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
3
Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.COVID-19 患者肠道微生物组中短链脂肪酸和 L-异亮氨酸生物合成的长期损伤。
Gastroenterology. 2022 Feb;162(2):548-561.e4. doi: 10.1053/j.gastro.2021.10.013. Epub 2021 Oct 21.
4
Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.评估与 SARS-CoV-2 感染相关的肠道和上呼吸道中的微生物群。
Microbiome. 2023 Mar 3;11(1):38. doi: 10.1186/s40168-022-01447-0.
5
The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.真菌肠道微生物组在严重 COVID-19 疾病中表现出多样性减少和子囊菌门相对丰度增加,并在 SARS-CoV-2 阳性患者中具有独特的相互关联的群落。
Front Cell Infect Microbiol. 2022 Apr 19;12:848650. doi: 10.3389/fcimb.2022.848650. eCollection 2022.
6
Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.人类肠道 RNA 和 DNA 病毒组在 SARS-CoV-2 感染及严重程度中的时变景观。
Microbiome. 2021 Apr 14;9(1):91. doi: 10.1186/s40168-021-01008-x.
7
Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses.通过整合多组学分析揭示 1 型糖尿病中口腔微生物组的改变及其对肠道微生物组的影响。
Microbiome. 2022 Dec 28;10(1):243. doi: 10.1186/s40168-022-01435-4.
8
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.
9
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.促炎肠道微生物组特征 SARS-CoV-2 感染患者,抗炎细菌网络连通性降低与严重 COVID-19 相关。
Front Cell Infect Microbiol. 2021 Nov 17;11:747816. doi: 10.3389/fcimb.2021.747816. eCollection 2021.
10
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.

引用本文的文献

1
Gut microbiota and viral respiratory infections: microbial alterations, immune modulation, and impact on disease severity: a narrative review.肠道微生物群与病毒性呼吸道感染:微生物变化、免疫调节及对疾病严重程度的影响:一项叙述性综述
Front Microbiol. 2025 Jul 18;16:1605143. doi: 10.3389/fmicb.2025.1605143. eCollection 2025.
2
Biological characteristics of SARS-CoV-2 resistant populations by integrated gut microbiota sequencing, metabolomics, and proteomics: a cohort comparison study.通过整合肠道微生物群测序、代谢组学和蛋白质组学分析SARS-CoV-2抗性人群的生物学特征:一项队列比较研究
Front Med (Lausanne). 2025 Jul 7;12:1593007. doi: 10.3389/fmed.2025.1593007. eCollection 2025.
3

本文引用的文献

1
Bacterial co-infections and antimicrobial resistance associated with the Coronavirus Disease 2019 infection.与 2019 年冠状病毒病感染相关的细菌合并感染和抗菌药物耐药性。
Biotechnol Genet Eng Rev. 2023 Oct;39(2):259-280. doi: 10.1080/02648725.2022.2122297. Epub 2022 Sep 19.
2
COVID-19 severity is associated with population-level gut microbiome variations.COVID-19 的严重程度与人群水平的肠道微生物组变化有关。
Front Cell Infect Microbiol. 2022 Aug 23;12:963338. doi: 10.3389/fcimb.2022.963338. eCollection 2022.
3
Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes.
Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19.
烟酰胺调节肠道微生物代谢潜能并加速轻至中度新冠肺炎的康复。
Nat Metab. 2025 May 12. doi: 10.1038/s42255-025-01290-1.
4
The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.肠道微生物群与鼻咽微生物群组成之间的关系可以预测新冠肺炎的严重程度。
Elife. 2025 Feb 18;13:RP95292. doi: 10.7554/eLife.95292.
5
The Multiple Challenges of Nutritional Microbiome Research During COVID-19-A Perspective and Results of a Single-Case Study.新冠疫情期间营养微生物组研究的多重挑战——一项单病例研究的观点和结果。
Nutrients. 2024 Oct 30;16(21):3693. doi: 10.3390/nu16213693.
6
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation.系统理解人类健康和疾病中微生物组的框架:从基础原理到临床转化。
Signal Transduct Target Ther. 2024 Sep 23;9(1):237. doi: 10.1038/s41392-024-01946-6.
7
The oral-gut microbiome axis in health and disease.口腔-肠道微生物轴在健康和疾病中的作用。
Nat Rev Microbiol. 2024 Dec;22(12):791-805. doi: 10.1038/s41579-024-01075-5. Epub 2024 Jul 22.
8
Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing.住院COVID-19患者的肠道微生物群动态变化及预测价值:浅层和深层鸟枪法测序的比较分析
Front Microbiol. 2024 Jun 19;15:1342749. doi: 10.3389/fmicb.2024.1342749. eCollection 2024.
9
Perturbations in gut microbiota composition in schizophrenia.精神分裂症患者肠道微生物群落组成的改变。
PLoS One. 2024 Jul 3;19(7):e0306582. doi: 10.1371/journal.pone.0306582. eCollection 2024.
10
Exploring Prior Antibiotic Exposure Characteristics for COVID-19 Hospital Admission Patients: OpenSAFELY.探索新冠病毒肺炎住院患者的既往抗生素暴露特征:OpenSAFELY研究。
Antibiotics (Basel). 2024 Jun 18;13(6):566. doi: 10.3390/antibiotics13060566.
通过宏基因组组装基因组解析人类微生物组在 COVID-19 中的作用。
Nat Commun. 2022 Sep 6;13(1):5235. doi: 10.1038/s41467-022-32991-w.
4
The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.新型冠状病毒感染患者中毛霉菌病(黑霉病)的影响:一目了然。
Environ Sci Pollut Res Int. 2022 Oct;29(46):69341-69366. doi: 10.1007/s11356-022-22204-8. Epub 2022 Aug 19.
5
Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity.根据2019年冠状病毒病初始疾病严重程度,12个月后的长期新冠症状及其对生活质量的影响。
Open Forum Infect Dis. 2022 Aug 5;9(8):ofac397. doi: 10.1093/ofid/ofac397. eCollection 2022 Aug.
6
MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections Among COVID-19 Patients: Observational Studies in Two Referral Hospitals in West Java, Indonesia.多重耐药病原体作为新冠病毒感染患者继发性肺部细菌感染死亡率的风险因素:印度尼西亚西爪哇两家转诊医院的观察性研究
Int J Gen Med. 2022 May 6;15:4741-4751. doi: 10.2147/IJGM.S359959. eCollection 2022.
7
Lost microbes of COVID-19: , depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity.新冠病毒丢失的微生物:与 SARS-CoV-2 感染严重程度相关的、耗尽和减少的微生物组多样性。
BMJ Open Gastroenterol. 2022 Apr;9(1). doi: 10.1136/bmjgast-2022-000871.
8
The immunology and immunopathology of COVID-19.新型冠状病毒肺炎的免疫学和免疫病理学。
Science. 2022 Mar 11;375(6585):1122-1127. doi: 10.1126/science.abm8108. Epub 2022 Mar 10.
9
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).新冠病毒患者的抗菌药物耐药性:系统评价和荟萃分析(2019 年 11 月至 2021 年 6 月)。
Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45. doi: 10.1186/s13756-022-01085-z.
10
Genome binning of viral entities from bulk metagenomics data.宏基因组数据中病毒类群的基因组分箱。
Nat Commun. 2022 Feb 18;13(1):965. doi: 10.1038/s41467-022-28581-5.